Follow
Stefanie Fekete
Stefanie Fekete
University Würzburg
Verified email at ukw.de
Title
Cited by
Cited by
Year
Dose-related concentrations of neuroactive/psychoactive drugs expected in blood of children and adolescents
S Fekete, C Hiemke, M Gerlach
Therapeutic drug monitoring 42 (2), 315-324, 2020
252020
Serious adverse drug reactions in children and adolescents treated on-and off-label with antidepressants and antipsychotics in clinical practice
KM Egberts, M Gerlach, CU Correll, PL Plener, U Malzahn, ...
Pharmacopsychiatry 55 (05), 255-265, 2022
222022
Therapeutic drug monitoring in children and adolescents under pharmacotherapy with olanzapine in daily clinical practice
S Fekete, C Wewetzer, C Mehler-Wex, K Holtkamp, R Burger, S Reichert, ...
Therapeutic drug monitoring 39 (3), 273-281, 2017
212017
Therapeutic drug monitoring of sertraline in children and adolescents: A naturalistic study with insights into the clinical response and treatment of obsessive-compulsive disorder
E Tini, L Smigielski, M Romanos, C Wewetzer, A Karwautz, K Reitzle, ...
Comprehensive psychiatry 115, 152301, 2022
192022
Therapeutic drug monitoring in children and adolescents with schizophrenia and other psychotic disorders using risperidone
R Taurines, S Fekete, A Preuss-Wiedenhoff, A Warnke, C Wewetzer, ...
Journal of Neural Transmission 129 (5), 689-701, 2022
172022
Estimation of a preliminary therapeutic reference range for children and adolescents with tic disorders treated with tiapride
S Fekete, K Egberts, T Preissler, C Wewetzer, C Mehler-Wex, M Romanos, ...
European journal of clinical pharmacology 77, 163-170, 2021
162021
Relationship between amphetamine concentrations in saliva and serum in children and adolescents with attention-deficit/hyperactivity disorder
C Wohkittel, P Högger, S Fekete, M Romanos, M Gerlach
Therapeutic Drug Monitoring 43 (4), 564-569, 2021
112021
Dose-corrected serum concentrations and metabolite to parent compound ratios of venlafaxine and risperidone from childhood to old age
S Fekete, M Scherf-Clavel, M Gerlach, M Romanos, S Kittel-Schneider, ...
Pharmacopsychiatry 54 (03), 117-125, 2021
92021
Therapeutic drug monitoring of children and adolescents treated with aripiprazole: observational results from routine patient care
K Egberts, SY Reuter-Dang, S Fekete, C Kulpok, C Mehler-Wex, ...
Journal of Neural Transmission 127, 1663-1674, 2020
92020
Selective serotonin reuptake inhibitors and suicidality in children and young adults: analyses of pharmacovigilance databases
D Dubrall, S Fekete, S Leitzen, LM Paschke, M Romanos, M Schmid, ...
BMC pharmacology and toxicology 24 (1), 22, 2023
82023
Therapeutic reference range for olanzapine in schizophrenia: systematic review on blood concentrations, clinical effects, and dopamine receptor occupancy
K Wesner, C Hiemke, N Bergemann, KM Egberts, S Fekete, M Gerlach, ...
The Journal of Clinical Psychiatry 84 (5), 47964, 2023
62023
Therapeutic drug monitoring in adolescents with anorexia nervosa for safe treatment with adjunct olanzapine
A Karwautz, M Zeiler, J Schwarzenberg, D Mairhofer, M Mitterer, ...
European Eating Disorders Review, 2023
52023
Therapeutisches Drug Monitoring zur Optimierung der Psychopharmakotherapie von Kindern und Jugendlichen
K Egberts, S Fekete, A Häge, C Hiemke, M Scherf-Clavel, R Taurines, ...
Zeitschrift für Kinder-und Jugendpsychiatrie und Psychotherapie, 2022
32022
Das pharmakologische Management kinder-und jugendpsychiatrischer Notfälle
TD Vloet, S Fekete, M Gerlach, M Romanos
Zeitschrift für Kinder-und Jugendpsychiatrie und Psychotherapie, 2021
32021
A Complex Intervention to Prevent Medication-Related Hospital Admissions: Results of the Stepped-wedge Cluster Randomized Trial KiDSafe in Pediatrics
A Neubert, I Toni, J König, MS Urschitz, W Rascher
Deutsches Ärzteblatt International 120 (25), 425, 2023
22023
Therapeutic drug monitoring to optimize psychopharmacotherapy in children and adolescents-Update and guidelines for practice
K Egberts, S Fekete, A Häge, C Hiemke, M Scherf-Clavel, R Taurines, ...
Zeitschrift fur Kinder-und Jugendpsychiatrie und Psychotherapie 50 (2), 133-152, 2021
22021
Therapeutic Drug Monitoring in Children and Adolescents: Findings on Fluoxetine from the TDM-VIGIL Trial
M Frey, L Smigielski, E Tini, S Fekete, C Fleischhaker, C Wewetzer, ...
Pharmaceutics 15 (9), 2202, 2023
12023
Serious Adverse Drug Reactions to Antipsychotics in Minors with Multiple Disabilities: Preventability and Potential Cost Savings by Therapeutic Drug Monitoring
S Fekete, T Güntzel, K Egberts, J Geissler, A Neubert, M Gerlach, ...
Pharmacopsychiatry 56 (01), 32-39, 2023
12023
Determination of Guanfacine in Oral Fluid and Serum of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Short Communication
C Wohkittel, O Scherf-Clavel, S Fekete, M Romanos, P Högger, M Gerlach
Therapeutic Drug Monitoring 44 (2), 340-344, 2022
12022
The Pharmacological Management of Emergencies in Child and Adolescent Psychiatry
TD Vloet, S Fekete, M Gerlach, M Romanos
Zeitschrift fur Kinder-und Jugendpsychiatrie und Psychotherapie 50 (4), 262-274, 2021
12021
The system can't perform the operation now. Try again later.
Articles 1–20